The Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights."
Dental membrane and bone graft substitutes are used in dental surgeries and procedures to promote bone regeneration and healing. These products provide structural support and enhance bone growth at dental defect sites. They mimic natural bone structures and support bone repair and remodeling through osteoconduction and osteoinduction.
Market key trends:
One of the key trends spurring market growth is the rising use of bone graft substitutes as an alternative to autografts. Autograft procedures require additional surgery to harvest bone from another part of the patient's body like hip or chin. Bone graft substitutes eliminate the need for secondary surgery and provide off-the-shelf grafting solutions. Synthetic bone graft substitutes can be easily shaped and molded as per the defect site and sterilized for safe use. They help reduce patient recovery time and risk of donor site morbidity associated with autografts. With advancements in material science, newer synthetic alternatives such as those made from ceramics, polymers and growth factors are being developed to better mimic the cellular microenvironment and enhance bone formation.
Threat of new entrants: The threat of new entrants is low as the dental membrane and bone graft substitute market requires huge R&D investments and regulatory approvals. Bargaining power of buyers: The bargaining power of buyers is moderate as the products offered by key players are differentiated based on application and material used. Bargaining power of suppliers: The bargaining power of suppliers is low due to availability of substitute products and inputs. Threat of new substitutes: The threat of new substitutes is moderate as new technologies are emerging however, clinical adoption may take time. Competitive rivalry: The competitive rivalry is high as the market is consolidated with presence of few global players.
Strengths: Wide range of product portfolio and strong global presence of key players. Increasing dental diseases and edentulism among aging population.
Weaknesses: High costs associated with development and marketing approval for new dental membrane and bone graft substitute products. Substitution threat from alternative therapies.
Opportunities: Growth opportunities in emerging markets. Widening medicare insurance coverage for dental surgeries.
Threats: Stringent regulatory framework for new product approvals. Reimbursement issues in developing countries.
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing prevalence of dental diseases. In 2023, the market is estimated to reach US$ 1,045.3 Mn.
Regional analysis: North America is expected to dominate the global dental membrane and bone graft substitute market during the forecast period. This is attributed to growing geriatric population, availability of advanced dental healthcare facilities and rising dental expenditure. Asia Pacific is anticipated to exhibit fastest growth over coming years.
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.